Vaccination of Adults with Cancer Guideline

Vaccination of Adults with Cancer Guideline

Up next

Breast Cancer Follow-Up and Surveillance After Primary Treatment Guideline Update

Drs. Zeina Nahleh and Maryam Lustberg join the podcast to discuss the updated ASCO guideline on breast cancer follow-up and surveillance after primary treatment. Drs. Nahleh and Lustberg explain the new risk-stratified approach, which personalizes surveillance intensity based on ...  Show more

Systemic Treatment of Ovarian Cancer Recurrence: ASCO Living Guideline 2026.1.0

Drs. Jamie Lesnock and Sara Bouberhan join the podcast to discuss the first ASCO guideline on systemic treatment for recurrent ovarian cancer. They provide a comprehensive overview of the evidence-based recommendations for patients with both platinum-sensitive and platinum-resist ...  Show more

Recommended Episodes

An Era of Promise for Cancer Vaccines
ASCO Daily News

Dr. Pedro Barata and Dr. Lillian Siu discuss recent advances in cancer vaccines and biomarkers, including the potential of the neoantigen and immune modulatory vaccines and the challenges surrounding cancer vaccine development.

<span style= "text-decoration: und ...

  Show more

Immunotherapy: Transforming How Cancers Are Treated
Cancer Straight Talk

In this episode, Dr. Diane Reidy-Lagunes talks to medical oncologist and scientist Dr. Jedd Wolchok and cancer survivor Grace Dunn. Together, they help decode the emerging new defense against cancer: immunology. For more information or to ask a question, please visit MSKCC.org/po ...  Show more

40 - Infectious Cancer Therapy
The Curious Clinicians

The Curious Clinicians examine why we use a bacterial vaccine (BCG, an attenuated form of mycobacterium bovis) to treat an unrelated malignancy (bladder cancer). Check out the show notes here. Click here to obtain AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance ...  Show more

TWiV 1265: mRNA vaccines make cancer treatment great again
This Week in Virology

TWiV explains studies showing that SARS-CoV-2 mRNA vaccines improve life span of cancer patients on checkpoint immunotherapy, and broad immunity conferred by a vaccine central in A(H5) influenza antigenic space.

<div class="fluid-width-video-wrapper">Hosts:   Show more